Buy CABAZITAXEL FOR INJECTION 45 MG CABAZITAXEL

Cabazitaxel for Injection 45 mg is a cancer treatment solution used to manage certain types of advanced cancer. This intravenous medication is designed to target cancer cells and is administered under medical supervision.

Strength

45 MG

Manufacturer / TM Owner

FORMATIVE PHARMA INC.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Uses / Indications

Cabazitaxel for Injection 45 mg is primarily used in the treatment of advanced prostate cancer. It is often prescribed for patients who have not responded to other treatments. This medication works by interfering with the division of cancer cells, helping to slow the progression of the disease. Patients typically receive this treatment in a clinical setting under the guidance of a healthcare professional.

Side Effects

Common effects of Cabazitaxel for Injection 45 mg may include fatigue, nausea, and a decrease in white blood cell count. Some patients may also experience diarrhea or hair loss. These effects can vary widely among individuals and should be discussed with a healthcare provider.

Precautions & Warnings

Cabazitaxel for Injection 45 mg should be handled with care and administered by trained medical professionals. It is important to follow all safety guidelines provided by the healthcare provider. Patients should inform their doctor about any existing medical conditions or allergies before starting treatment.

Avoid Interactions

Cabazitaxel for Injection 45 mg may interact with other medications, including those that affect the immune system or blood cell production. It is important to discuss all current medications with a healthcare provider to avoid potential interactions. Alcohol and certain foods may also affect the efficacy of this treatment.

References

Frequently Asked Questions

Cabazitaxel for Injection 45 mg is used to treat advanced prostate cancer in patients who have not responded to other treatments.

Cabazitaxel for Injection 45 mg is administered intravenously by a healthcare professional in a clinical setting.

Common side effects may include fatigue, nausea, diarrhea, and a decrease in white blood cell count.

It is important to discuss all current medications with a healthcare provider to avoid potential interactions.

Patients with certain medical conditions or allergies should consult their healthcare provider before taking Cabazitaxel for Injection 45 mg.

Published by GNH India Pharmaceuticals Limited

Last updated: 17 Jun 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.